Article Information
History
- December 30, 2022.
Article Versions
- You are currently viewing Version 1 of this article (December 30, 2022 - 16:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- 1Systems Biology Division, National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration, Jefferson, AR
- 2NCTR / ORA Nanotechnology Facility, Office of Scientific Coordination, National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration, Jefferson, AR
- 3Division of Microbiology, National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration, Jefferson, AR
- ↵*Corresponding author:
Dan Buzatu, Mailing address:
Systems Biology Division, National Center for Toxicological Research, 3900 NCTR Rd., Jefferson, AR 72079. Phone: 1-870-543-7287. E-mail: Dan.Buzatu{at}fda.hhs.gov
Note: The co-authors have all contributed equally to this work.